~~<i id='4C5ECD1D41'><strike id='4C5ECD1D41'><tt id='4C5ECD1D41'><pre id='4C5ECD1D41'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

fashion

author：knowledge 2025-08-19 20:47:30 - browse：1

Sarepta Therapeutics said Monday afternoon that its gene therapy for Duchenne muscular dystrophy failed to improve muscle function compared to a placebo in a large clinical trial — likely a major disappointment for patients and doctors who have been desperately awaiting the treatment for years.

The company said all patients in the study improved and that secondary measurements indicated the drug was having an effect. Nevertheless, the results are likely to raise questions about whether the Food and Drug Administration will expand access to the medicine.

Trading in Sarepta shares was halted at $107 with the release of the study results.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： FDA gives detailed accounting of AI

knowledge

explore

knowledge

1:28PeoplegatherinpreparationforaQueerMarchtotheTexasStateCapitolonApril15,2023inAustin,Texas.Brando

WSS

Why 40% Americans with Parkinson’s don’t see a neurologist

STAT Summit: Michael J. Fox on progress in Parkinson's research

Studies point to risks of excluding people with obesity from drug trials

Will Ozempic

CEOs share strategies for surviving biotech slump

FDA struggles to regulate food additives, sometimes for decades

hotspot

fashion

knowledge

Apple is now the first public company to be valued at $3 trillion

2023 STAT Wunderkinds: get to know the winners

Walensky prepares to leave CDC — and Congress — behind

HCA discloses massive data breach affecting 11 million patients

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Living with Fabry disease, a condition that causes chronic pain

Virginia high school admissions case could be legal follow

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

Psychedelics group wrestles with new pharma identity

STAT Summit: Biotech founders on deal

knowledge

Hospital price transparency does save money, advocate argues

Eli Lilly expects to double planned employment in Boston center

STAT Summit: How a Chicago ER doctor tackles gun violence

Study: Pain burden is higher in Black NFL players than white ones

Study: Pain burden is higher in Black NFL players than white ones

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

knowledge

explore

knowledge

knowledge